Morepen Laboratories Limited (NSE:MOREPENLAB)

Market Cap	35.30B
Revenue (ttm)	18.30B
Net Income (ttm)	1.18B
Shares Out	n/a
EPS (ttm)	2.20
PE Ratio	29.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,840,731
Average Volume	6,219,523
Open	64.75
Previous Close	64.47
Day's Range	63.50 - 64.89
52-Week Range	42.00 - 100.90
Beta	0.79
RSI	56.97
Earnings Date	Aug 7, 2025

About Morepen Laboratories

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermome...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 2,152
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MOREPENLAB

Financial Performance

In 2024, Morepen Laboratories's revenue was 18.30 billion, an increase of 7.52% compared to the previous year's 17.02 billion. Earnings were 1.18 billion, an increase of 22.73%.